Tony Moody, MD is an Instructor in the Department of Pediatrics, Division of Infectious Diseases at Duke University Medical Center and a faculty member of the Duke Human Vaccine Institute. Dr. Moody serves as the CHAVI Chief Medical Officer and oversees the CHAVI B cell Immune Monitoring Core. He is the Principal Investigator of the CHAVI 005 clinical protocol, “Analysis of Host Response to HIV-1 in Autoimmune Disease Patients” and the 008A clinical protocol “Molecular Characterization of HIV-1 Neutralizing Antibody Breadth and Potency in Natural Infection.”
The Moody laboratory supports CHAVI 001 and 012 efforts to understand the evolution of the B cell response to HIV-1 infection. The lab is responsible for the initial phases of the Antibodyome project and provides one of the downstream assays used in the study. The lab also provides core laboratory support for the production of antigen-specific reagents for the CHAVI B cell team and custom conjugation of antibodies for their own lab and CHAVI colleagues at Duke University. Ongoing research in the lab includes the development of new conjugation chemistries for these reagents and novel adjuvants for CHAVI work.
Dr. Moody received his B.S. from Duke University in 1989 followed by his M.D. from Duke University School of Medicine in 1999. He completed his Residency in Categorical Pediatrics at Emory University School of Medicine in 2002 and served as Pediatric Chief Resident from 2002-2003. In 2006, Dr. Moody completed his Fellowship in Pediatric Infectious Diseases at Duke University. He was selected by Dr. Samuel Katz to receive the fellowship portion of the Pollin Prize in Pediatric Research in 2007.
Dr. Moody is a Fellow of the American Academy of Pediatrics (FAAP). He is a member of the American Chemical Society, the American Academy of Pediatrics, the American Board of Pediatrics, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Research Affairs Committee of PIDS.